Hey Kombuchayum- I suggest you speak with the poster Photofool about your issues. Although, Photofool hasn't posted in awhile, you may be able to catch him and call him out?
The offering price of MSFT stock was $21.00 per share at the IPO on March 13, 1986. If you had bought 1 share at the offering, you would now have 288 split-adjusted shares. So you would be worth 288 * 27.69 = $7,974.72
An interesting way to look at the increase in Microsoft, since it went public:
If you look at today's MSFT closing price of $27.69 down 6 cents; the March 1986 IPO price, accounting for 9 splits, would have cost you 9.7 cents. That would be almost what MSFT lost in value today. So 970 cents invested i.e. $9.70, would now be worth $2,769.00. Although quite a good record, the stock has lost value since its peak of about $60 in early 2000.
And you wonder why your cries for attention are irrelevant to those who are practical thinkers. Your probably a good guy, get treatment.
I thought you died in a head on car crash with AF. Your ego is on a Weiner leash. Give it up, recognize all of your purported logic has only entertainment value.
Yea- I suspect Reed's hasn't done anything in the spirit of marketing to create brand awareness. After all, they probably envisioned dropping a product on the shelf and instantly carving away market share. Remember, you've built a reputation for yourself by being less than a talking head.
Upon PMA approval for cardio indication. There is no other roto rooter device which is safe and effective at cleaning the drains of clogged heart patients. Seeing, that heart attacks kill most people, approval of the Atherectomy 360 will be huge. Expect a huge splash, unlike the response for that new (THERMO) device for clearing blockage in asthma patients.
Its a blatantly dumb question- The world doesn't know about Kombucha except folks in category corner of the room. The Kombucha message must reach all types of consumers to take off.
EVOL vs partnering or some form of integration.